-
1 Comment
Colfax Corporation is currently in a long term uptrend where the price is trading 12.0% above its 200 day moving average.
From a valuation standpoint, the stock is 96.2% cheaper than other stocks from the Industrials sector with a price to sales ratio of 2.0.
Colfax Corporation's total revenue sank by 6.8% to $828M since the same quarter in the previous year.
Its net income has increased by 297.0% to $33M since the same quarter in the previous year.
Finally, its free cash flow grew by 137.9% to $96M since the same quarter in the previous year.
Based on the above factors, Colfax Corporation gets an overall score of 4/5.
ISIN | US1940145022 |
---|---|
Sector | Industrials |
Industry | Specialty Industrial Machinery |
CurrencyCode | USD |
Exchange | NYSE |
Beta | 2.12 |
---|---|
Dividend Yield | 0.0% |
Target Price | 50.42 |
PE Ratio | 28.55 |
Market Cap | 2B |
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CFX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024